Clinical Trials Browser

Phase 2 × Advanced, Persistent, or Recurrent Endometrial Cancer × Everolimus × Clear all

NCT02228681 2024-09-19

Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

Phase 2 Completed

74 enrolled 13 charts

Advanced, Persistent, or Recurrent Endometrial Cancer